Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-05-22
1997-10-07
Seidleck, James J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
424464, 424468, 424474, 424475, 424479, 424480, 424484, 424486, 424488, A01N 3744, A61K 3124
Patent
active
056748957
ABSTRACT:
A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4063064 (1977-12-01), Saunders et al.
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4111202 (1978-09-01), Theeuwes et al.
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4783337 (1988-11-01), Wong et al.
patent: 4800098 (1989-01-01), Ayer et al.
patent: 4816263 (1989-03-01), Ayer et al.
patent: 4824675 (1989-04-01), Wong et al.
patent: 4863456 (1989-09-01), Stephens et al.
patent: 4902514 (1990-02-01), Barclay et al.
patent: 5399359 (1995-03-01), Baichwal
"General principles for designing with plastics" by P. Grafton, 1969-1970 Modern Plastics Encyclopedia, vol. 46, pp. 62-70.
"Preparation of Compressed Tablet Granulations by the Air-Suspension Technique II" by Dale E. Wurster, J. of Amerc. Phar. Association vol. 49 No. 2, pp. 82-84, Feb. 1960.
"Air-Suspension Technique of Coating Drug Particles" by Dale E. Wurster, J. Am Phar. Assoc. Sci. Ed., vol. 48, pp. 451454, Aug. 1959.
Pharmaceutical Science, By Remington, 14th Ed., pp. 1626-1979, (1970).
Chemical Abstracts, vol. 120, No. 18, May 2, 1994, Abstract No. 227011.
Chemical Abstracts, vol. 120, No. 14, Apr. 4, 1994, Abstract No. 173499.
Guittard George V.
Gumucio Fernando
Jao Francisco
Kidney David J.
Marks Susan M.
ALZA Corporation
Dillahunty Mary Ann
Rafa Michael J.
Sabatine Paul L.
Seidleck James J.
LandOfFree
Dosage form comprising oxybutynin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage form comprising oxybutynin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form comprising oxybutynin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357722